Delivery Order SPE2DB20D2104-SPE2DB22FS69J
- Not listed
- This contract award, valued at $11,072.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Multaq 400 mg tablets, a cardiovascular medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a wide...
- This federal contract award, valued at $1,936.65, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4564413056 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,920.54 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,053.59 for the supply of MULTAQ 400 MG TABLET 60S. The contract has a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $11,364.29 firm fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of a specific pharmaceutical product, 4554554270 ! MULTAQ 400 MG TABLET 60S, to support military treatment facilities and veterans' healthcare programs. The award has no set-aside designation, indicating open competition. The IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX15D1053|SPE2DX24F6GJK) from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $12,545.49 firm fixed-price contract is for the delivery of 4563590220 MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
- This federal contract award, valued at $27,349.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Multaq 400 mg tablets, a cardiovascular medication. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX24F0JZA) with a Firm Fixed Price valued at $24,340.63. The award is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that supports military healthcare programs. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award, valued at $14,879.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Multaq 400 mg tablets, with a completion date of February 22, 2024. The contract type is Firm Fixed Price, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,676.69 delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $7,676.69 and runs through December 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS69JDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Multaq 400 mg Tablet 60s. The $2,942.61 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) as part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical pharmaceutical distributor and solutions provider to the U.S. federal government, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/11/22 |